Medindia

X

Business & Decision Brings its eClinical Life Sciences Industry offering to North America

Wednesday, November 14, 2007 General News J E 4
Advertisement
PHILADELPHIA, Nov. 13 Business & Decision(www.businessdecision.com) announced the launch of its North AmericaneClinical Division. This line of business will focus on providingPharmaceutical, Biotechnology, Medical Device and CRO companies with a rangeof eClinical IT Services and Solutions.

At the helm of this new business is 20 year Life Science veteran, KathrynHanson, Director of eClinical Services and Solutions. "We are very pleased tohave Kathryn in this role, her subject matter expertise in the eClinicaldomain is extensive" says Bill Fitch, North American Life Sciences VicePresident.

Initially, our services and solutions will include business processconsulting, implementation and technical services, application training, ITcompliance and validation, application hosting, and managed services forOracle's Life Sciences product suite.

Business & Decision will focus its services around the Oracle Clinical,Remote Data Capture and Thesaurus Management System and Siebel Clinical TrialsManagement System suite of applications.

Business & Decision's North American Life Sciences practice (formerlyknown as Mi Services Group) has long been recognized internationally as thepremier leader in IT Compliance and Computer System Validation for EnterpriseSystems (ERP, MES MRPII, LIMS). In Europe, current capabilities aroundclinical data management, clinical analytics, CDISC integration and CROstaffing services in the clinical space are clearly defined and widelyrecognized across the market.

"The North American eClinical offering will elevate Business & Decision'smarket standing as an International service provider with a superior breadthand depth of industry acumen. We expect to see significant penetration in thismarket in 2008, in part through our Certified Advantage Oracle partnership andalso through our position in the European market." says Bill Fitch.

"Our reputation as an integrator of choice for Oracle's E-Business Suiteis well established, and the addition of eClinical solutions is both a naturalextension of our services and a confirmation of Oracle's leadership in thisvital industry." commented Robin Kearon, CEO Business & Decision, NorthAmerica.

About Business & Decision

Founded in 1992, Business & Decision is an international engineering andconsulting firm specializing in Business Intelligence, Customer RelationshipManagement and ERP.

With more than 2,500 employees worldwide, Business & Decision hasdeveloped a 'complete project approach' that spans from consultation toimplementation. The Group has a reputation for its functional andtechnological expertise and has forged partnerships with key technologyvendors. At present, Business & Decision has more than 1,200 clients includingGE Healthcare, AICPA, AMPAC Fine Chemicals, CONMED Linvatec, Keystone Foods,Novartis, OSI Pharmaceuticals, Merck Serono and Teva Pharmaceuticals.

Business & Decision has been listed on the EuroNext Paris since February2001 (compartment C / Isin code: FR 00000 7895 8 / Symbol: BND). Business &Decision is listed in the NextEconomy segment and in the technology market.

For more information, visit: www.businessdecision.com .

About the Oracle PartnerNetwork

Oracle PartnerNetwork is a global business network of 15,000 companies whodeliver innovative software solutions based on Oracle software. Through accessto Oracle's premier products, education, technical services, marketing andsales support, the Oracle PartnerNetwork program provides partners with theresources they need to be successful in today's global economy. Oraclepartners are able to offer customers leading-edge solutions backed by Oracle'sposition as the world's largest enterprise software company. Partners who areable to demonstrate superior product knowledge, technical expertise and acommitment to doing business with Oracle can
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
AMA Adopts New Ethical Policies on Umbilical Cord ...
S
AMA Commends Aetna for Quality First Commitment